Feature Channels: Personalized Medicine

Filters close
Released: 8-Aug-2022 4:05 PM EDT
暴露组探索:妙佑医疗国际(Mayo Clinic) 有关环境暴露对健康影响的研究
Mayo Clinic

来自空气、食物、产品和水中的环境化学物质、污染物、微生物和微粒可能会蓄积在我们每个人的体内。这些有时有害的暴露物会与我们的基因发生相互作用,从而引发疾病。妙佑医疗国际个体化医学中心的研究人员正在研究终生环境暴露(称为暴露组),并评估对这些暴露产生的生物反应。

Released: 8-Aug-2022 4:05 PM EDT
مايو كلينك تلقي الضوء على آثار التعرّض لمختلف العوامل البيئية على صحّة الإنسان
Mayo Clinic

تحتوي أجسادنا على تراكمات سنوات طويلة من المواد الكيميائية والملوّثات والميكروبات والجسيمات المتواجدة في البيئة المحيطة به، والتي نتعرّض لها يومياً عبر الهواء الذي نتنشّقه والطعام الذي نتناوله والمنتجات التي نلمسها والماء الذي نشربه.

Released: 8-Aug-2022 3:05 PM EDT
Exploración del exposoma: Mayo Clinic estudia el impacto de la exposición ambiental sobre la salud
Mayo Clinic

Dentro de cada uno de nosotros puede existir una acumulación de sustancias químicas y contaminantes del ambiente, de microbios y de partículas adquiridas del aire que respiramos, de los alimentos que comemos, de los productos que tocamos y del agua que bebemos.

Released: 4-Aug-2022 3:30 PM EDT
Genetic findings offer opportunity for personalized heart failure treatment
Brigham and Women’s Hospital

Heart failure is a common and devastating disorder for which there is no cure. Many cardiomyopathies —conditions that make it difficult for the heart to pump blood such as dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM) — can lead to heart failure, but treatments for patients with heart failure do not take these distinct conditions into account.

Newswise: CHOP Helps Develop Platform to Speed Up Drug Development for Kids with Cancer
Released: 4-Aug-2022 10:15 AM EDT
CHOP Helps Develop Platform to Speed Up Drug Development for Kids with Cancer
Children's Hospital of Philadelphia

Children’s Hospital of Philadelphia (CHOP) has helped launch a new computational platform that will harmonize pediatric cancer data, allowing researchers, pharmaceutical companies, and advocacy groups to accelerate the pace of drug development for pediatric cancer. With funding from the National Cancer Institute (NCI) via a subcontract with Leidos Biomedical Research, current operator of the NCI’s Frederick National Laboratory for Cancer Research, CHOP researchers have created the Molecular Targets Platform to facilitate pediatric research in response to the Research to Accelerate Cures and Equity (RACE) for Children Act, which requires companies to test cancer drugs in children that are used in adults when there is a shared molecular target.

Released: 1-Aug-2022 5:05 PM EDT
What to Look For in a Physical Therapy Facility
Hospital for Special Surgery

After an injury or surgery, physical therapy often plays an essential role in recovery. It can also improve fitness and function for people dealing with chronic pain. Experts from Hospital for Special Surgery offer tips on what to look for in a PT facility.

Released: 29-Jul-2022 2:05 PM EDT
Don't give up the fight. Read the latest news about drug and antibiotic resistance
Newswise

Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.

Newswise: Increased Precision and Safety in Spinal Tap with PASS – An Ultrasound-Guided Lumbar Puncture Procedure
Released: 29-Jul-2022 8:55 AM EDT
Increased Precision and Safety in Spinal Tap with PASS – An Ultrasound-Guided Lumbar Puncture Procedure
Chulalongkorn University

PASS (Point-Assisted Spinal Sonography), an ultrasound-guided lumbar puncture device from Chula doctors and engineers, helps increase the precision and confidence in spinal tap procedures while reducing risks and pain for patients.

19-Jul-2022 2:05 PM EDT
ACP Offers Guidance on the Ethical Use of Genetic Testing and Precision Medicine
American College of Physicians (ACP)

A new position paper from the American College of Physicians (ACP) offers guidance regarding ethical decision-making for the integration of precision medicine and genetic testing into internal medicine. ACP's advice is published in Annals of Internal Medicine.

Newswise: Major Expansion Announced for Vanderbilt University Hospital
Released: 25-Jul-2022 10:25 AM EDT
Major Expansion Announced for Vanderbilt University Hospital
Vanderbilt University Medical Center

Leaders with Vanderbilt University Medical Center announced plans today for construction of the largest expansion to date for Vanderbilt University Hospital (VUH). Through this project a new inpatient tower will be built atop an existing parking structure located between 21st Avenue South and Medical Center Drive.

20-Jul-2022 12:00 PM EDT
Artificial Intelligence in Personalized Medicine, Genomic Sequencing Advances, Human Brain Organogenesis, Building Trust with Patients, Guiding Patient Decisions with Mass Spectrometry, and Much More to Be Explored at 2022 AACC
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.

   
Newswise: Engineers Develop New Tool That Will Allow for More Personalized Cell Therapies
Released: 20-Jul-2022 10:00 AM EDT
Engineers Develop New Tool That Will Allow for More Personalized Cell Therapies
University of Minnesota College of Science and Engineering

A University of Minnesota Twin Cities team has developed a new tool to predict and customize the rate of DNA editing, paving the way for more personalized, efficient genetic and cell therapies for diseases such as diabetes and cancer.

   
Released: 15-Jul-2022 12:00 PM EDT
A New Treatment Approach for Cystic Fibrosis
Cold Spring Harbor Laboratory

Antisense oligonucleotides, or ASOs, are molecules that can be used to control protein levels in cells.

Newswise: Microfluidic-Based Soft Robotic Prosthetics Promise Relief for Diabetic Amputees
21-Jun-2022 11:00 AM EDT
Microfluidic-Based Soft Robotic Prosthetics Promise Relief for Diabetic Amputees
American Institute of Physics (AIP)

In Biomicrofluidics, scientists reveal their development of a new type of prosthetic using microfluidics-enabled soft robotics that promises to greatly reduce skin ulcerations and pain in patients who have had an amputation between the ankle and knee. They started with a recent device that uses pneumatic actuators and miniaturized the actuators by designing a microfluidic chip with 10 integrated pneumatic valves to control each actuator. The control box is small and light enough to be worn as part of the prosthesis.

   
Released: 27-Jun-2022 1:45 PM EDT
The latest expert commentary on SCOTUS decisions, including the overturn of Roe v. Wade
Newswise

The latest expert commentary and research on SCOTUS decisions, including the overturn of Roe v. Wade

       
Released: 24-Jun-2022 9:00 AM EDT
MD Anderson and Turning Point Therapeutics Announce Strategic Alliance to Advance Precision Cancer Therapies
University of Texas MD Anderson Cancer Center

MD Anderson and Turning Point Therapeutics announced a strategic research and development alliance to evaluate Turning Points investigational targeted therapies against ROS1, NTRK, MET and other cancer drivers.

Released: 22-Jun-2022 12:50 PM EDT
New Understanding of Congenital Heart Disease Progression Opens Door to Improved Treatment Options
Texas Children's Hospital

A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of Medicine uncovered new insights into the mechanisms underlying the progression of congenital heart disease (CHD) ― a spectrum of heart defects that develop before birth and remain the leading cause of childhood death.

Released: 22-Jun-2022 10:30 AM EDT
Amid Surgical Mesh Concerns, Surgeons Are Asked: What Treatment Would You Choose for Yourself?
Wolters Kluwer Health: Lippincott

There is a long history of confusion and controversy regarding the use of polypropylene mesh materials for pelvic floor disorders in women, such as stress urinary incontinence (SUI) or pelvic organ prolapse (POP). So what option would specialist surgeons choose if they were to undergo these procedures themselves? That's the question asked in a survey study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 21-Jun-2022 3:30 PM EDT
University of Maryland Medicine Launches Precision Health Study to Create Biggest and Most Diverse Research Database in State
University of Maryland School of Medicine

University of Maryland Medicine, the joint enterprise of the University of Maryland School of Medicine, the University of Maryland Medical Center, and University of Maryland Medical System, today launched a landmark initiative called My Healthy Maryland Precision Medicine Research.

Released: 21-Jun-2022 12:10 PM EDT
Scientists Unravel Genetic Mystery of Rare Neurodevelopmental Disorder, Provide Definitive Diagnoses to 21 Families Worldwide
Mayo Clinic

A collaborative team of scientists led by Mayo Clinic's Center for Individualized Medicine has discovered 15 additional genetic mutations in the KCNK9 gene that cause a neurodevelopmental syndrome.

Released: 14-Jun-2022 3:15 PM EDT
"Yes, optimists live longer" and more research news on Aging for media
Newswise

Here are some of the latest articles that have been added to the Aging channel on Newswise, a free source for journalists.

       
Released: 12-Jun-2022 10:05 PM EDT
NUS AI Platform Enables Doctors to Optimise Personalised Chemotherapy Dose
National University of Singapore (NUS)

A team of researchers from National University of Singapore, in collaboration with clinicians from the National University Cancer Institute, Singapore which is part of the National University Health System, has reported promising results in using CURATE.AI, an artificial intelligence tool that identifies and better allows clinicians to make optimal and personalised doses of chemotherapy for patients.

   
Released: 9-Jun-2022 3:55 PM EDT
Choosing Wisely® Campaign Adds Five More “Things Physicians and Patients Should Question” to Prevent Unnecessary Tests and Procedures
American Medical Society for Sports Medicine (AMSSM)

The American Medical Society for Sports Medicine (AMSSM) recently updated its Choosing Wisely® recommendations to include five new suggestions to reduce low-value or overutilized medical services.

Newswise: Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children’s Hospital of Philadelphia’s Transformative, Personalized Cancer Therapy
Released: 9-Jun-2022 11:50 AM EDT
Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children’s Hospital of Philadelphia’s Transformative, Personalized Cancer Therapy
Perelman School of Medicine at the University of Pennsylvania

The behind-the-scenes story detailing the pursuit of a transformative cancer cure will unfold onscreen at the Tribeca Film Festival in New York City this weekend. “Of Medicine and Miracles,” which will premiere during the renowned international festival, is an emotional journey, revealing decades of research – and one young patient’s family’s last hopes to save their daughter – that culminated in the world’s first CAR T-cell therapy, an approach that reprograms patients’ own immune cells to kill their cancer.

Newswise: Penn Medicine Developed CAR T Cell Therapy Wins Third FDA Approval
Released: 31-May-2022 9:35 AM EDT
Penn Medicine Developed CAR T Cell Therapy Wins Third FDA Approval
Perelman School of Medicine at the University of Pennsylvania

The U.S. Food and Drug Administration (FDA) has expanded its approval for a personalized cellular therapy developed at the University of Pennsylvania’s Abramson Cancer Center, this time for the treatment of adults with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. The accelerated approval was granted today to Novartis for the chimeric antigen receptor (CAR) T-cell therapy Kymriah® (tisagenlecleucel), making it the third indication for the nation’s first personalized cellular therapy for cancer. It remains the only CAR-T cell therapy approved for both adult and pediatric patients.

Newswise: Penn Medicine and Children’s Hospital of Philadelphia Announce Partnership with Costa Rica for CAR T Cell Therapy
Released: 23-May-2022 1:35 PM EDT
Penn Medicine and Children’s Hospital of Philadelphia Announce Partnership with Costa Rica for CAR T Cell Therapy
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine and Children’s Hospital of Philadelphia (CHOP), who together pioneered the research and development of the world’s first personalized cellular therapy for cancer — also known as CAR T cell therapy — have announced plans with Costa Rica’s CCSS, or the Caja Costarricense de Seguro Social (Social Security Program), to facilitate CAR T research in Costa Rica.

Newswise: Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer
Released: 20-May-2022 9:45 AM EDT
Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer
Yale Cancer Center/Smilow Cancer Hospital

Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.

Newswise: Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Released: 19-May-2022 10:05 AM EDT
Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Rutgers Cancer Institute of New Jersey

Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.

Newswise: UT Austin Researchers Change the Cancer Equation
Released: 17-May-2022 11:25 AM EDT
UT Austin Researchers Change the Cancer Equation
Oden Institute for Computational Engineering and Sciences

A major donation has enabled the launch of an exciting new interdisciplinary collaboration at UT Austin involving the Oden Institute for Computational Engineering and Sciences, Machine Learning Labs and Dell Medical School.

Newswise: Groundbreaking for Major Expansion of University of Maryland Greenebaum Comprehensive Cancer Center
Released: 13-May-2022 10:00 PM EDT
Groundbreaking for Major Expansion of University of Maryland Greenebaum Comprehensive Cancer Center
University of Maryland Medical Center

The University of Maryland Medical Center celebrates the groundbreaking of a nine-story patient care tower – the Roslyn and Leonard Stoler Center for Advanced Medicine – that will become the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. The $219 million building will enable the cancer center to provide the most technologically advanced, integrated care to cancer patients throughout Maryland and the region well into the future

Released: 12-May-2022 4:05 PM EDT
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai Announce a Joint Center for Engineering and Precision Medicine in New York City
Mount Sinai Health System

Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai today announced the creation of the Center for Engineering and Precision Medicine (CEPM), one of the first centers in the nation to bridge engineering and engineering science with medicine. This undertaking will build on a wealth of shared basic research discoveries, explore unique therapeutic innovations in cancer, Alzheimer’s and a myriad of infectious diseases; educate a new generation of biomedical leaders; and develop new technologies and processes that enhance patient outcomes in unprecedented ways. CEPM represents an evolution in the successful partnership between Mount Sinai and RPI, one that has secured over $70 million in shared research funding since 2013 with 90 percent of that provided by the National Institutes of Health.

Released: 12-May-2022 6:00 AM EDT
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai Announce a Joint Center for Engineering and Precision Medicine in New York City
Rensselaer Polytechnic Institute (RPI)

Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai today announced the creation of the Center for Engineering and Precision Medicine (CEPM), one of the first centers in the nation to bridge engineering and engineering science with medicine.

Released: 10-May-2022 2:45 PM EDT
Discovery in the brains of army veterans with chronic pain could pave way for personalized treatments
Frontiers

A new study is the first to investigate brain connectivity patterns at rest in veterans with both chronic pain and trauma, finding three unique brain subtypes potentially indicating high, medium, and low susceptibility to pain and trauma symptoms.

Released: 6-May-2022 10:35 AM EDT
Targeting Cervical Cancer Stem Cells to Improve Outcomes
Sbarro Health Research Organization (SHRO)

The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.

Released: 3-May-2022 9:30 AM EDT
Featured Speakers Announced for NUTRITION 2022 LIVE ONLINE
American Society for Nutrition (ASN)

Get the latest insights from leading nutrition scientists and practitioners at NUTRITION 2022 LIVE ONLINE, the flagship online meeting of the American Society for Nutrition. Explore the meeting program for scientific sessions, special events and featured speakers.

Released: 29-Apr-2022 9:55 AM EDT
妙佑医疗国际(Mayo Clinic)研究人员通过CAR-T细胞装载溶瘤病毒治疗实体癌肿瘤
Mayo Clinic

妙佑医疗国际(Mayo Clinic)个体化医学中心的研究人员设计出一种免疫治疗技术,通过将嵌合抗原受体-T细胞疗法,即CAR-T细胞疗法与一种抗癌病毒相结合,更有效地靶向和治疗实体癌肿瘤。

Released: 29-Apr-2022 9:50 AM EDT
باحثو مايو كلينك يقومون بتحميل الخلايا التائية ذات مستقبلات المستضد الخيمرية ذات الفيروس المحلل للورم لعلاج الأورام السرطانية الصلبة
Mayo Clinic

ابتكر باحثون من مركز مايو كلينك للطب الفردي أسلوبًا للعلاج المناعي يجمع بين العلاج بالخلايا التائية ذات مستقبلات المستضد الخيمرية، أو العلاج بخلايا CAR-T، والفيروس قاتل السرطان لاستهداف الأورام السرطانية الصلبة وعلاجها بشكل أكثر فعالية

Released: 29-Apr-2022 9:45 AM EDT
Pesquisadores da Mayo Clinic carregam células CAR-T com vírus oncolítico para tratar tumores sólidos
Mayo Clinic

Pesquisadores do Centro de Medicina Individualizada da Mayo Clinic criaram uma técnica de imunoterapia que combina terapia de células T com receptor de antígeno quimérico, ou terapia celular CAR-T, com um vírus que mata o câncer para direcionar melhor o alvo e tratar com mais eficiência tumores de câncer sólidos.

Released: 28-Apr-2022 5:05 PM EDT
Investigadores de Mayo Clinic llenan con virus oncolítico a células T con receptor de antígeno quimérico para tratar cáncer de tumor sólido
Mayo Clinic

Los investigadores del Centro para Medicina Personalizada en Mayo Clinic inventaron una técnica de inmunoterapia que combina la terapia de células T con receptor de antígeno quimérico (CAR-T, por sus siglas en inglés) con un virus que elimina el cáncer a fin de apuntar de forma más eficiente el tratamiento contra el cáncer de tumor sólido.

Newswise:Video Embedded live-event-for-april-28th-the-tuskegee-syphilis-study-50-years-later-why-it-still-matters
VIDEO
Released: 28-Apr-2022 4:05 PM EDT
VIDEO AND TRANSCRIPT of Live Event for April 28th: The Tuskegee Syphilis Study 50 Years Later. Why It Still Matters
Newswise

It’s been 50 years since the Tuskegee Study was disclosed to the American public. In May, a new riveting account of the Study, when government doctors intentionally withheld effective therapy for syphilis for 40 years in 400 African American men, will be published in the American Journal of Respiratory and Critical Care Medicine. The article explains the deeper everlasting lessons of the study.

       
27-Apr-2022 10:05 AM EDT
Scientists Awaken Viral Response to Target Bowel Cancer
Queen's University Belfast

New research has identified the role of the immune response within bowel cancer tissue, which could lead to new lifesaving treatments for bowel cancer patients.

Released: 20-Apr-2022 11:05 AM EDT
Flexible printable electrical patches for accelerated wound healing
Terasaki Institute for Biomedical Innovation

There are myriad ways in which people can experience physical wounds – from minor scrapes and abrasions to the effects of surgery, critical injuries, burns and other major traumas.

Released: 19-Apr-2022 5:45 PM EDT
Newly developed genetic risk scores could help patients, physicians make health decision
Brigham and Women’s Hospital

A person’s risk of developing diseases such as type 2 diabetes or breast cancer may be influenced by thousands of genetic differences.

14-Apr-2022 12:05 AM EDT
Study uses machine-learning approach to calculate risk for veteran homelessness
Uniformed Services University of the Health Sciences (USU)

In the U.S. today, there are an estimated 1.4 million homeless veterans, which makes up about eight percent of the country’s homeless population. Though it has been difficult to accurately predict homelessness before it occurs, a new collaborative study using a “personalized medicine” approach, led by the Uniformed Services University (USU), suggests self-reported lifetime depression and posttraumatic stress disorder were among the most important factors that put veterans at risk for becoming homeless.

   
11-Apr-2022 6:00 AM EDT
Mayo Clinic researchers load CAR T cells with oncolytic virus to treat solid cancer tumors
Mayo Clinic

Researchers at Mayo Clinic's Center for Individualized Medicine have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors.

Released: 5-Apr-2022 3:55 PM EDT
The latest news on clinical trials is here on Newswise
Newswise

Here are some of the latest articles that have been added to the Clinical Trials channel on Newswise.

       
Released: 5-Apr-2022 12:45 PM EDT
Is digital health just for the rich?
Annual Reviews

Despite COVID-19 forcing the hand of digitally reticent governments and health organizations to update, upskill and adopt digital health tools, evidence of scaled up mobile phone health (mHealth) initiatives being accessible to the poorest and those most in need, is so far, thin on the ground, according to the review released today in the Annual Review of Public Health.

   


close
1.58564